News & Media
Dr. Gerold Morton Grodsky (Professor of Biochemistry & Biophysics and Medicine, UCSF, Emeritus, Active), science professor and bon vivant, who found humor in life, and provided warmth and support to...
US Food and Drug Administration (FDA) approved the use of Teplizumab under the brand name Tzield, an immunotherapy drug, which has been shown to significantly delay the onset of type 1 diabetes. This...
Thursday November 3, 2022 9:00a-5:00p Join us to celebrate the 20th anniversary of the UCSF Diabetes Center. Hear from our distinguished researchers who will share updates on their groundbreaking...
Last year the World Health Organization (WHO) launched the NCD LAB, an initiative leveraging community-driven grassroots innovations with the potential to be game changers in beating non-communicable...
A personal investigation into the lifelong implications of his type 1 diabetes culminated in a $7 million gift from Mike Gordon, co-founder of Meritech Capital Partners, and his wife, Loren, to help...